Pfizer and its German partner BioNTech asked London's Court of Appeal on Thursday to overturn a ruling that their COVID-19 ...

Moderna said Friday that the European Patent Office has upheld the validity of one of its key patents, a victory in a continuing dispute with Pfizer and BioNTech over rival COVID-19 vaccines.

Pfizer (NYSE:PFE) and BioNTech (NASDAQ:BNTX), its partner for the Comirnaty COVID-19 vaccine, made legal submissions to ...

The lawsuit, filed by Moderna, sets up a clash between rival vaccine makers who used novel mRNA technology to speed delivery of shots.

Moderna wins a crucial legal battle at the European Patent Office against Pfizer and BioNTech over Covid-19 vaccine patents.

Pfizer Inc PFE, BioNTech SE BNTX, and Moderna Inc MRNA were named in lawsuits by Promosome accusing their COVID-19 vaccines of infringing a patent related to messenger RNA (mRNA) technology. The ...

Pfizer Inc and its German partner, BioNTech SE , fired back at Moderna Inc on Monday in a patent lawsuit over their rival COVID-19 vaccines, seeking dismissal of the lawsuit in Boston federal ...

Three of the biggest COVID-19 vaccine developers are heading into a legal battle. Moderna Inc. said it has filed lawsuits alleging the Pfizer Inc.-Biontech SE Comirnaty vaccine infringes patents ...

Pfizer and BioNTech exercised legal authorization to use their patent until May 2023. The court made a decision that Moderna legally withdrew their consent in March 2022 so their previous patent ...

Moderna on Friday filed patent infringement lawsuits against Pfizer and BioNTech “for infringing patents central to (its) mRNA technology platform,” the company said in a news release Friday.

Moderna has also been sued for patent infringement in the United States and has an ongoing dispute with the US National Institutes of Health over rights to mRNA technology.

European Patent Office Sides with Moderna In COVID-19 Vaccine Patent Dispute With Pfizer/BioNTech Vandana Singh Fri, May 17, 2024, 2:46 PM2 min read ...